Concepedia

Diana Bradford

DB

Statistics

Publications

17

Citations

922

H-Index

13

Active since

2015

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

National Cancer Institute

Massachusetts General Hospital

Children's National

Diana Bradford is an author at United States Food and Drug Administration specializing in medicine, oncology, and clinical trials.

ORCID

Top concepts

Publications per year

2015–2025

17

Publications

17

FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with <i>RET</i> Gene Mutations or Fusions

Diana Bradford, Erin Larkins, Sirisha L. Mushti et al. · Clinical Cancer Research · 2020 · 161 citations

FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease–Associated Tumors

Jaleh Fallah, Michael H. Brave, Chana Weinstock et al. · Clinical Cancer Research · 2022 · 149 citations · Full text

, , +21

FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With <i>RET</i> Gene Mutations or Fusions

Janice Kim, Diana Bradford, Erin Larkins et al. · Clinical Cancer Research · 2021 · 99 citations

, , +16

Current Treatment Options for Malignant Peripheral Nerve Sheath Tumors

Diana Bradford, AeRang Kim · Current Treatment Options in Oncology · 2015 · 85 citations

, , +4

Current whole-body MRI applications in the neurofibromatoses

Shivani Ahlawat, Laura M. Fayad, Muhammad Shayan Khan et al. · Neurology · 2016 · 85 citations · Full text

1–5 of 17